TABLE 2.
Vaccine schedule (mo) | General population | IBD cohort | |
---|---|---|---|
Standard dosing | 0, 1, 6 (1.0 ml, 20 µg recombinant HBsAg) | >90% a | 41% b |
Accelerated double dosing | 0, 1, 2, 12 (2 × 1.0 ml, 20 µg recombinant HBsAg) | >90% a | 75% b |
Kubba A et al Commun Dis Public Health. 2013.
Gisbert J et al Aliment Pharmacol Ther. 2012.